Literature DB >> 32348229

Across the "Sweetest" Properties of Human Breast Milk: Focus on Oligosaccharides.

Flaminia Bardanzellu1, Alessandra Reali1, Maria A Marcialis1, Vassilios Fanos1.   

Abstract

INTRODUCTION: Breast Milk (BM), containing nutrients and bioactive components, represents the best source for neonatal nutrition and determines short- and long- term benefits. Human milk oligosaccharides (HMOs) play an active role in these pathophysiological mechanisms. In fact, they influence the shaping of breastfed infant's gut microbiota, promote intestinal development, confer protection against intestinal or systemic infections modulating immune system; moreover, HMOs determine extra-intestinal effects on several target organs, i.e reducing necrotizing enterocolitis rate or improving brain development. AIMS: In this review, we analyze the great inter- and intra-individual variability of BM HMOs, investigating maternal, genetic and environmental factors modulating their composition. Moreover, we provide an update regarding HMOs' unique properties, underlining their complex interaction with intestinal microbiota and host-derived metabolites. The possible HMOs' influence on extraintestinal bacterial communities, potentially influencing newborns' and even lactating mothers' health, have been hypothesized. Finally, recognized HMOs' crucial role, we underline the promising opportunities showed by their addition in formula milk, to make it more similar to maternal milk itself. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  HMOs; Human breast milk; microbiota; necrotizing enterocolitis; neonatal nutrition; premature newborns

Year:  2020        PMID: 32348229     DOI: 10.2174/1573396316666200429114217

Source DB:  PubMed          Journal:  Curr Pediatr Rev        ISSN: 1573-3963


  1 in total

Review 1.  The Human Breast Milk Metabolome in Overweight and Obese Mothers.

Authors:  Flaminia Bardanzellu; Melania Puddu; Diego Giampietro Peroni; Vassilios Fanos
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.